[The effect of Cavinton on patients susceptible to arrhythmia studied by ECG monitoring].
D000328:Adult; D000368:Aged; D001145:Arrhythmias, Cardiac / Q000139:chemically induced*; D002301:Cardiac Glycosides / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004347:Drug Interactions; D004562:Electrocardiography; D005260:Female; D006801:Humans; D007008:Hypokalemia / Q000150:complications; D008297:Male; D008875:Middle Aged; D008991:Monitoring, Physiologic; D014748:Vinca Alkaloids / Q000009:adverse effects*
D002301:Cardiac Glycosides; D014748:Vinca Alkaloids; C013983:vinpocetine
A Cavinton hatásának vizsgálata EKG monitorozással aritmiára hajlamos betegekben.